In a recent study, the overall concordance for TP53 alterations was 59.5% (47/79 mutations) when cfDNA fraction was <1.5% and reached 86.3% (69/80 mutations) when tumor fraction was ≥1.5% (p-value < 0.001) [31]. This evidence concerns the gene TP53 and neoplasm.